
BBIO's Q2 loss misses estimates, but revenues beat expectations as Attruby sales more than tripled, fueling growth and pipeline advances.
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

BBIO's Q2 loss misses estimates, but revenues beat expectations as Attruby sales more than tripled, fueling growth and pipeline advances.

Adjusted EBITDA surged 34% on LS Power integration and smart home growth.

CoreWeave, Inc. (NASDAQ:CRWV) reports second-quarter earnings after the close today, with the call at 5 p.m. ET. Analysts expect revenue of roughly $2.56 billion, more than double the year-ago figure, alongside a loss of about $1.40 per share. The stock...

Aehr Test Systems has surged over 400% this year on a dramatic business transformation, but with a price-to-sales ratio that would make most investors flinch and insiders quietly selling into the rally, the question now is whether the momentum has any room left to run.

Walmart stock is in focus with earnings due Aug. 20. Here's how to reach for profit with a short-term options trade on the retailer.

Silicon photonics run rate reached $680 million, targeting $1 billion by year-end.

Revenue surged across all channels as TransDigm raised full-year guidance.

Spotify hits 300 million premium subscribers and record 33.4% gross margin.
TJX Companies (TJX) is set to deliver "in-line" Q2 EPS report and raise guidance, with limited impac

Cardinal Health beats fiscal Q4 EPS estimates as profit surges, while revenues miss; fiscal 2027 guidance points to continued earnings growth.

Hims & Hers Health, Inc. reported second-quarter 2026 sales of US$753.21 million, up from US$544.83 million a year earlier, but moved from net income of US$42.51 million to a net loss of US$86.29 million, while also raising full-year 2026 revenue guidance to between US$3.10 billion and US$3.30 billion and issuing higher third-quarter revenue expectations. Alongside this growth outlook, the company is rolling out an AI-powered, personalized weight loss experience on the Hers app, supported by...

Co-CEO David Allemann said On Holding is winning over what it calls the “movement class,” consumers who view fitness as part of their identity.

Agnico Eagle Mines stock has delivered a very large 3 year return, while current valuation checks suggest it is closer to fairly valued than clearly cheap. The Discounted Cash Flow (DCF) estimate and earnings multiples point to only a modest valuation gap rather than an obvious mispricing. Agnico Eagle Mines has returned about 3x over the last 3 years, which puts extra focus on whether recent gains are already reflected in the current share price. Recent higher earnings and a maintained...

RIG beats Q2 earnings estimates as Harsh environment floaters deliver stronger revenues, utilization and day rates despite lower sales.
Target's (TGT) Q2 results should reflect continued traction with its turnaround efforts, with manage

MNDY tops Q2 estimates as revenues rise 22%, operating margin expands and AI product ARR doubles from Q1 amid growing enterprise traction.

Non-COVID products surge 5% as Pfizer raises guidance and targets $9.7B in savings.

Oncology and animal health drove $16.6B revenue growth amid upcoming patent expirations.

Record $20.5B quarterly sales driven by data center demand and a $72B backlog.
Rocket Lab Stock Tumbles After Earnings. Weak Margin Guidance Sparks Selloff
Plug Power Stock Rallies on Strong Q2 Results and a Major Margin Turnaround

Vistra's Q2 call keeps 2026 guidance intact as data center demand supports long-term growth, while softer ERCOT pricing clouds its 2027 outlook.
Okta (OKTA) could deliver about 2 percentage points of upside to the midpoint of its fiscal Q2 2027
A site visit and local planning hearing led DA Davidson to question whether Nebius can finish its New Jersey data-center project this year, putting forecast upside and its execution record…

Archer Aviation is surging for a second straight day while rivals Joby and EHang sit completely frozen, and the reason traces back to a Boeing deal detail that changes how Archer plans to fund its entire future.
CoreWeave Inc (NASDAQ:CRWV) reports second-quarter earnings tonight, with Jefferies maintaining a Buy rating and $150 price target even as it flags that a major profitability inflection is still months away. CoreWeave shares have climbed roughly 45% since hyperscaler earnings reaffirmed...

RGTI's Q2 revenues surge 185% as QPU sales and technology gains boost momentum, but heavy losses and uneven demand keep caution in focus.
Hims & Hers Health raised its 2026 revenue outlook to between $3.1 billion and $3.3 billion from its earlier guidance between $2.8 billion and $3 billion.

RadNet tops Q2 estimates as advanced imaging and Digital Health growth accelerate, prompting a higher 2026 Imaging Center outlook.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.